While genomics has opened new avenues in infectious disease research, it also presents challenges and ethical considerations that warrant careful attention. The vast amount of genomic data generated raises concerns about data privacy, security, and the responsible use of genetic information. Safeguarding sensitive genomic data is crucial to prevent unintended consequences, such as stigmatization or discrimination based on genetic traits. Another challenge lies in the global disparities in genomic research capabilities and resources. Ensuring equitable access to genomic technologies and the benefits of genomic research is essential to address infectious diseases that disproportionately affect marginalized populations. Ethical considerations extend to the use of genomic data for bioterrorism or dual-use research, where information generated for scientific purposes could potentially be misused for harmful intentions. Striking a balance between advancing scientific knowledge and preventing misuse is a complex ethical dilemma that requires ongoing dialogue and international collaboration.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain